ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2813

Interferon-Induced APOL1 over-Expression Causes Autophagic Dysfunction and Mitochondrial Stress in Risk Variant-Carrying Endothelial Cells

Ashira Blazer1, Sara Rasmussen2, Androo Markham3, Shilpi Mehta-Lee4, Jill P. Buyon4 and Robert M. Clancy2, 1Division of Rheumatology, NYU School of Medicine, New York, NY, 2Department of Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 3Medicine, NYU School of Medicine, New York, NY, 4NYU School of Medicine, New York, NY

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: African-Americans, endothelial cells, genetics and interferons, Lupus

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis I

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose:

In SLE Apolipoprotein L1 (APOL1) risk variants (RV) associate with cardiovascular and end stage renal disease. APOL1 induction initially promotes cellular maintenance through autophagy; but when prolonged disrupts lipid bilayers causing ion flux, mitochondrial stress, and cell death. We hypothesized that cytokine-induced RV expression impairs autophagy favoring pore formation in endothelial cells (ECs) implicating endothelial dysfunction as a mechanism for broader organ damage.

Methods: ECs were isolated from umbilical cords of 11 healthy African American subjects and genotyped for APOL1 by PCR sequencing (G0/G0 n=4, RV/G0 n=4 RV/RV n=3). CD31+ ECs (confirmed by FACS) were treated with IFNɣ (100 units/mL) for 24 hours and subsequent assessments included: APOL1 and autophagy marker LC3B protein measurements by immunoblot, LC3B staining by immunofluorescence, angiogenesis capacity on Matrigel matrix, and bioenergetic profiling by the Seahorse mitochondrial stress test method.

Results:

EC were >98% CD31 positive by flow cytometry. Across the genotypes, exposure to IFNɣ increased APOL1 protein expression 13.3±9.2 fold (p=0.012). To assess the ability of APOL1 over-expression to initiate autophagy, LC3B positive autophagosomes were counted by immunofluorescence. As expected, in G0/G0 ECs autophagosomes increased 41% when APOL1 was over-expressed. By contrast, autophagosomes decreased 7.1% in RV/G0 and 35.5% RV/RV ECs suggesting an autophagy defect. This result was confirmed by immunoblot. Autophagy-dependent angiogenesis was evaluated by plating resting and IFNɣ treated ECs on Matrigel matrix. At baseline, RV/RV ECs showed impaired angiogenesis capacity forming fewer junctions (J) and tubules (T) than RV/G0 and G0/G0 ECs (RV/RV: J: 539.9, T: 484.8; RV/G0: J: 841.8, T: 727.7, G0/G0: J: 810.8 T: 719.0, p=0.07). Overexpressing APOL1 with IFNɣ, impaired angiogenesis in both the RV/RV and RV/G0 ECs but not G0/G0 ECs (RV/RV: J: 353.0 T: 319.8; RV/G0: J: 297.8, T: 296.0, G0/G0: J: 739.0 T: 657.8, p=0.001). As a proof of concept, autophagy inhibitor ABT-737 was added to G0/G0 ECs resulting in a 42% decrease in junctions (p=0.036) and 52% decrease in tubules (p=0.012). Mitochondrial oxygen consumption of resting and IFNɣ treated ECs, was next assessed by bioenergetic profiling. For baseline, there were genotype-dependent differences in spare capacity (SC) and coupling efficiency (CE) (G0/G0: SC: 41.0±22.0 pmol/min CE: 439.8%; RV/G0: SC: 22.75 pmol/min±0.18 CE:119.9%; RV/RV SC: 24.6±4.71 pmol/min CE:100.35%). Upon adding IFNɣ, Proton leak increased 1.89 pmol/min in the G0/G0 ECs, 1.49 pmol/min in the RA/G0 ECs, and 7.50 pmol/min in the RA/RA ECs. This pattern is consistent with genotype dependent increased cation pore formation with electron escape across the inner mitochondrial membrane.

Conclusion:

IFNɣ increases both ancestral and variant APOL1 intracellular accumulation in cultured ECs across genotype. In RV carrying ECs, this increased expression results in aberrant autophagy, angiogenesis, and mitochondrial energy production, all of which likely contribute to endothelial dysfunction, representing an underpin of broader organ damage.


Disclosure: A. Blazer, None; S. Rasmussen, None; A. Markham, None; S. Mehta-Lee, None; J. P. Buyon, Exagen, 2; R. M. Clancy, None.

To cite this abstract in AMA style:

Blazer A, Rasmussen S, Markham A, Mehta-Lee S, Buyon JP, Clancy RM. Interferon-Induced APOL1 over-Expression Causes Autophagic Dysfunction and Mitochondrial Stress in Risk Variant-Carrying Endothelial Cells [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/interferon-induced-apol1-over-expression-causes-autophagic-dysfunction-and-mitochondrial-stress-in-risk-variant-carrying-endothelial-cells/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/interferon-induced-apol1-over-expression-causes-autophagic-dysfunction-and-mitochondrial-stress-in-risk-variant-carrying-endothelial-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology